E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/18/2006 in the Prospect News Biotech Daily.

Access Pharmaceuticals common stock listed on OTC Bulletin Board

By Lisa Kerner

Erie, Pa., May 18 - Access Pharmaceuticals, Inc. said its common stock is now trading on the OTC Bulletin Board under the trading symbol AKCA after the company's appeal to the American Stock Exchange for continued listing was denied.

Access was delisted because it had losses from continuing operations and/or net losses in two of its most recent fiscal years with shareholders' equity of less than $2 million; the company had losses from continuing operations and/or net losses in three of its most recent fiscal years with shareholders' equity of less than $4 million; and it had losses from continuing operations and/or net losses in four of its most recent fiscal years with shareholders' equity of less than $6 million.

Dallas-based Access is an emerging pharmaceutical company developing polymer linked cytotoxics for use in the treatment of cancer.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.